Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.
Clinical insights
Key research benefits
A 28-amino-acid thymic peptide approved in 35+ countries (as Zadaxin) for chronic hepatitis and as a cancer-therapy adjunct — one of the most studied peptides in this guide.
- 86% viral DNA clearance vs. 20% with placebo in a controlled hepatitis B trial.
- Cut flu incidence from 19% to 6% in a 90-patient elderly trial while boosting vaccine antibody response.
- Cancer adjunct data linked to a median survival of 38.4 months vs. 8 months when added to checkpoint-inhibitor therapy in a melanoma trial.
Research backing
Over 11,000 human subjects across 30+ trials — the deepest human evidence base in this guide. Note: the large 2025 BMJ TESTS sepsis trial (n=1,089) found no mortality benefit, illustrating that effect sizes shrink in the largest, highest-quality trials.
Research Grade Formula
Thymosin Alpha-1
Healing & Recovery
Thymosin Alpha-1 · 10mg
$120
Express Shipping $20 — Australia only
- Third-party tested
- Non-GMO
- GMP certified
How to use
Follow research handling and reconstitution guidance for this compound. Always use appropriate lab technique and sterile materials.
Research Dosage ProtocolWhat's inside
Each vial contains research-grade Thymosin Alpha-1 · 10mg supplied as a freeze-dried solid for laboratory preparation. Material is intended for controlled research workflows only.
Technical overview
- Form: Lyophilized powder in a sealed research vial
- Purity target: ≥99% with batch Certificate of Analysis
- Reconstitution: Use bacteriostatic water under sterile technique
- Storage: Keep dry and cool until reconstituted; refrigerate after mixing
Reconstitute with bacteriostatic water at room temperature. For laboratory research and educational use only — not for human consumption.
Customer reviews
4.9
Based on 312 reviews
